AZN | ||
|---|---|---|
OUTLOOK RATING 1..100 | 16 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 24 Undervalued | |
PROFIT vs RISK RATING 1..100 | 27 | |
SMR RATING 1..100 | 45 | |
PRICE GROWTH RATING 1..100 | 44 | |
P/E GROWTH RATING 1..100 | 50 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| AGNG | AZN | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 79% | 1 day ago 47% |
| Stochastic ODDS (%) | 1 day ago 75% | 1 day ago 43% |
| Momentum ODDS (%) | 1 day ago 77% | 1 day ago 61% |
| MACD ODDS (%) | 1 day ago 85% | 1 day ago 55% |
| TrendWeek ODDS (%) | 1 day ago 82% | 1 day ago 56% |
| TrendMonth ODDS (%) | 1 day ago 82% | 1 day ago 56% |
| Advances ODDS (%) | 3 days ago 85% | 4 days ago 55% |
| Declines ODDS (%) | 22 days ago 77% | 22 days ago 43% |
| BollingerBands ODDS (%) | 1 day ago 72% | 1 day ago 40% |
| Aroon ODDS (%) | 1 day ago 83% | 1 day ago 41% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FIICX | 18.83 | N/A | N/A |
| Fidelity Advisor Mid Cap II C | |||
| FRIRX | 12.23 | N/A | N/A |
| Fidelity Advisor Real Estate Income I | |||
| BGPKX | 13.94 | -0.13 | -0.92% |
| Baillie Gifford Developed EAFE All Cap K | |||
| VKSEX | 9.77 | -0.11 | -1.11% |
| Virtus KAR Small-Mid Cap Value C | |||
| CTSOX | 45.03 | -2.27 | -4.80% |
| Calamos Timpani Small Cap Growth R6 | |||
A.I.dvisor indicates that over the last year, AGNG has been closely correlated with ALC. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if AGNG jumps, then ALC could also see price increases.
| Ticker / NAME | Correlation To AGNG | 1D Price Change % | ||
|---|---|---|---|---|
| AGNG | 100% | -0.43% | ||
| ALC - AGNG | 67% Closely correlated | -1.04% | ||
| SYK - AGNG | 60% Loosely correlated | +1.66% | ||
| BIIB - AGNG | 58% Loosely correlated | +2.01% | ||
| AZN - AGNG | 54% Loosely correlated | +1.06% | ||
| GMAB - AGNG | 54% Loosely correlated | -0.75% | ||
More | ||||
A.I.dvisor indicates that over the last year, AZN has been loosely correlated with GSK. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if AZN jumps, then GSK could also see price increases.